HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CSCI

COSCIENS Biopharma Inc

Last Close
Dec 10 • 04:00PM ET
2.85
Dollar change
+0.19
Percentage change
7.03 		%
Healthcare • Biotechnology • Canada • NASD
Peers: AMGN GILD REGN VRTX BIIB BMY MRNA LLY INCY NBIX
Scroll to Statements
Index- P/E- EPS (ttm)-26.09 Insider Own1.57% Shs Outstand3.12M Perf Week0.87%
Market Cap8.89M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.07M Perf Month-14.93%
Income-18.56M PEG- EPS next Q- Inst Own0.55% Short Float0.17% Perf Quarter-29.63%
Sales4.33M P/S2.05 EPS this Y- Inst Trans- Short Ratio0.92 Perf Half Y-61.16%
Book/sh6.41 P/B0.44 EPS next Y- ROA-43.04% Short Interest0.01M Perf Year-66.15%
Cash/sh6.41 P/C0.44 EPS next 5Y- ROE-80.20% 52W Range2.62 - 11.10 Perf YTD-61.69%
Dividend Est.- P/FCF- EPS past 5Y- ROI-87.46% 52W High-74.32% Beta1.52
Dividend TTM- Quick Ratio3.05 Sales past 5Y103.89% Gross Margin37.30% 52W Low8.78% ATR (14)0.20
Dividend Ex-Date- Current Ratio3.46 EPS Y/Y TTM-35.52% Oper. Margin-486.85% RSI (14)39.11 Volatility4.39% 6.90%
Employees21 Debt/Eq0.08 Sales Y/Y TTM-36.86% Profit Margin-428.43% Recom1.00 Target Price60.00
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q45.74% Payout- Rel Volume0.78 Prev Close2.66
Sales Surprise- EPS Surprise- Sales Q/Q62266.67% EarningsNov 12 BMO Avg Volume5.57K Price2.85
SMA20-4.89% SMA50-16.18% SMA200-51.14% Trades Volume4,347 Change7.03%
Nov-12-24 07:30AM
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
(GlobeNewswire) -10.18%
Oct-08-24 07:30AM
COSCIENS Biopharma Announces Change to Board of Directors
(GlobeNewswire)
Oct-01-24 05:30PM
COSCIENS Biopharma Announces Appointment of Pierre Labb as Director
(GlobeNewswire)
05:30PM
COSCIENS Biopharma Announces Appointment of Pierre Labbe as Director
(GlobeNewswire)
Sep-23-24 07:30AM
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
(GlobeNewswire) -5.58%
07:30AM Loading…
Aug-27-24 07:30AM
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
(GlobeNewswire) -32.42%
Aug-13-24 08:05AM
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
(GlobeNewswire)
COSCIENS Biopharma Inc. Is a specialty biopharmaceutical company, which engages in the development and commercialization of diverse pharmaceutical and diagnostic products. The company is headquartered in Toronto, Canada.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.